Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for Travere Therapeutics, Inc., €194k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Roy Baynes: trading record in brief
Roy Baynes has a single filing on record, published on 12 June 2026: a transaction of €194k in Travere Therapeutics, Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Roy Baynes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 4,500 shares@ US$50.000.0042% mcap100.0% of flowCommonSEC144:0001950047-26-005979
1 of 1 declaration
